A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt

Angiogenesis

Volumn 14, Issue 3, 2011, Pages 355-369

  Mehta, Rajeshwari R ^a   Yamada, Tohru ^a   Taylor, Brad N ^a   Christov, Konstantin ^a   King, Marissa L ^b   Majumdar, Dibyen ^b   Lekmine, Fatima ^a   Tiruppathi, Chinnaswamy ^a   Shilkaitis, Anne ^a   Bratescu, Laura ^a   Green, Albert ^a   Beattie, Craig W ^a   Das Gupta, Tapas K ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Akt; Angiogenesis; Azurin; FAK; HUVEC; p53

Indexed keywords

AZURIN; CAVEOLIN 1; CD31 ANTIGEN; DACARBAZINE; F ACTIN; FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; PAXILLIN; PROTEIN KINASE B; PROTEIN P28; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CAPILLARY PROLIFERATION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; DOWNSTREAM PROCESSING; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; ANIMALS; ANTIGENS, CD31; ANTINEOPLASTIC AGENTS; AZURIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL-PENETRATING PEPTIDES; CLINICAL TRIALS, PHASE II AS TOPIC; ENDOTHELIAL CELLS; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; HUMANS; MICE; MICE, NUDE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOMONAS AERUGINOSA; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

PSEUDOMONAS AERUGINOSA;

EID: 80052722389     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-011-9220-6     Document Type: Article

References (56)

1. J Folkman 2006 Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action Exp Cell Res 312 594 607 16376330 10.1016/j.yexcr.2005.11. 015 1:CAS:528:DC%2BD28XhvVWltbY%3D (Pubitemid 43290336)
2. J Folkman 2006 Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin Sci STKE 2006 pe35 17003465 10.1126/stke.3542006pe35
3. WH Lien CK Chen LY Lai YH Chen MP Wu LW Wu 2004 Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence Biochem Pharmacol 68 729 738 15276080 10.1016/j.bcp.2004.05.020 1:CAS:528:DC%2BD2cXmtVWhsrk%3D (Pubitemid 38953454)
4. D Ingber T Fujita S Kishimoto, et al. 1990 Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 555 557 1701033 10.1038/348555a0 1:CAS:528:DyaK3MXpsVOntw%3D%3D (Pubitemid 120015110)
5. RP Singh K Raina G Sharma R Agarwal 2008 Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice Clin Cancer Res 14 7773 7780 19047104 10.1158/1078-0432.CCR-08-1309 1:CAS:528:DC%2BD1cXhsVegtrfO
6. RP Singh S Dhanalakshmi C Agarwal R Agarwal 2005 Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy Oncogene 24 1188 1202 15558015 10.1038/sj.onc.1208276 1:CAS:528:DC%2BD2MXhtFGqs7o%3D (Pubitemid 40313920)
7. W Wen J Lu K Zhang S Chen 2008 Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway Cancer Prev Res (Phila) 1 554 561 10.1158/1940-6207.CAPR-08-0040 1:CAS:528:DC%2BC3cXptFKns7k%3D
8. BR Binder 2007 A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis Circ Res 100 13 14 17204660 10.1161/01.RES.0000255897.84337.38 1:CAS:528: DC%2BD2sXhsFSis74%3D (Pubitemid 46066770)
9. DM Moran CG Maki 2010 Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cells Mol Cancer Ther 9 895 905 20371712 10.1158/1535-7163.MCT-09-1220 1:CAS:528:DC%2BC3cXktlCqt7o%3D
10. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6 273 286 17396134 10.1038/nrd2115 1:CAS:528: DC%2BD2sXjs1SisL4%3D (Pubitemid 46505878)
11. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 1027 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D (Pubitemid 46202320)
12. M Korc RE Friesel 2009 The role of fibroblast growth factors in tumor growth Curr Cancer Drug Target 9 639 651 10.2174/156800909789057006 1:CAS:528:DC%2BD1MXhtFehtb7P
13. WC Dempke R Zippel 2010 Brivanib, a novel dual VEGF-R2/bFGF-R inhibitor Anticancer Res 30 4477 4483 21115896 1:CAS:528:DC%2BC3MXhs1aitg%3D%3D
14. V Punj S Bhattacharyya D Saint-Dic, et al. 2004 Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer Oncogene 23 2367 2378 14981543 10.1038/sj.onc.1207376 1:CAS:528:DC%2BD2cXisVGks7Y%3D (Pubitemid 38496792)
15. DS Yang XD Miao ZM Ye, et al. 2005 Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells Pharmacol Res 52 413 421 16026999 10.1016/j.phrs.2005.06.002 1:CAS:528:DC%2BD2MXhtFKnsLfI (Pubitemid 41531161)
16. D Apiyo P Wittung-Stafshede 2005 Unique complex between bacterial azurin and tumor-suppressor protein p53 Biochem Biophys Res Commun 332 965 968 15913547 10.1016/j.bbrc.2005.05.038 1:CAS:528:DC%2BD2MXltFCltb0%3D (Pubitemid 40798181)
17. V De Grandis AR Bizzarri S Cannistraro 2007 Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin J Mol Recognit 20 215 226 17703463 10.1002/jmr.840 (Pubitemid 47523028)
18. M Taranta AR Bizzarri S Cannistraro 2008 Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy J Mol Recognit 21 63 70 18247358 10.1002/jmr.869 1:CAS:528:DC%2BD1cXjtFCltLk%3D (Pubitemid 351300460)
19. V Punj TK Das Gupta AM Chakrabarty 2003 Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53 Biochem Biophys Res Commun 312 109 114 14630027 10.1016/j.bbrc.2003.09.217 1:CAS:528: DC%2BD3sXptVelsLg%3D (Pubitemid 37443934)
20. BN Taylor RR Mehta T Yamada, et al. 2009 Noncationic peptides obtained from azurin preferentially enter cancer cells Cancer Res 69 537 546 19147567 10.1158/0008-5472.CAN-08-2932 1:CAS:528:DC%2BD1MXltFSiuw%3D%3D
21. T Yamada RR Mehta F Lekmine, et al. 2009 A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells Mol Cancer Ther 8 2947 2958 19808975 10.1158/1535-7163.MCT-09-0444 1:CAS:528: DC%2BD1MXht1Cqur%2FI
22. Jia L, Gorman G, Coward L, et al. (2010) Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemother Pharmacol 1-12. doi: 10.1007/s00280-010-1518-3
23. EK Ueda HL Lo P Bartolini AM Walker 2006 S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells Endocrinology 147 4627 4637 16840547 10.1210/en.2006-0348 1:CAS:528:DC%2BD28XhtVSksb3P (Pubitemid 44402168)
24. S Rauth J Kichina A Green L Bratescu TK Das Gupta 1994 Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice Anticancer Res 14 2457 2463 7872667 1:CAS:528:DyaK2MXltlejt74%3D
25. C Tiruppathi AB Malik PJ Del Vecchio CR Keese I Giaever 1992 Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function Proc Natl Acad Sci USA 89 7919 7923 1518814 10.1073/pnas.89.17.7919 1:CAS:528:DyaK3sXhvVOgsw%3D%3D
26. TA Fong LK Shawver L Sun, et al. 1999 SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types Cancer Res 59 99 106 9892193 1:CAS:528:DyaK1MXmsFOgug%3D%3D (Pubitemid 29062964)
27. TJ Wright L Leach PE Shaw P Jones 2002 Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells Exp Cell Res 280 159 168 12413882 10.1006/excr.2002.5636 1:CAS:528:DC%2BD38XotFGgs78%3D (Pubitemid 35333758)
28. F Dunphy BC Stack Jr JH Boyd TL Dunleavy HJ Kim CH Dunphy 2002 Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy Anticancer Res 22 1755 1758 12168864 (Pubitemid 34839191)
29. P Secchiero F Corallini A Gonelli, et al. 2007 Antiangiogenic activity of the MDM2 antagonist nutlin-3 Circ Res 100 61 69 17138942 10.1161/01.RES. 0000253975.76198.ff 1:CAS:528:DC%2BD28XhtlGiurjN (Pubitemid 46066774)
30. N Sheibani PJ Newman WA Frazier 1997 Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis Mol Biol Cell 8 1329 1341 9243511 1:CAS:528:DyaK2sXkvVamsbw%3D (Pubitemid 27310478)
31. S Esser MG Lampugnani M Corada E Dejana W Risau 1998 Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells J Cell Sci 111 Pt 13 1853 1865 9625748 1:CAS:528:DyaK1cXkvVKmt7s%3D (Pubitemid 28370530)
32. J Wu N Sheibani 2003 Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases J Cell Biochem 90 121 137 12938162 10.1002/jcb.10600 1:CAS:528:DC%2BD3sXnsVGiu7w%3D (Pubitemid 37052315)
33. T Yamada M Goto V Punj, et al. 2002 Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer Proc Natl Acad Sci USA 99 14098 14103 12393814 10.1073/pnas.222539699 1:CAS:528:DC%2BD38XosF2itrc%3D (Pubitemid 35257631)
34. T Yamada Y Hiraoka M Ikehata, et al. 2004 Apoptosis or growth arrest: modulation of tumor suppressor p53's specificity by bacterial redox protein azurin Proc Natl Acad Sci USA 101 4770 4775 15044691 10.1073/pnas.0400899101 1:CAS:528:DC%2BD2cXjsFCjtbY%3D (Pubitemid 38469152)
35. ZM Ye XD Miao DS Yang RZ Xu X Huang FF Ge 2005 Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS Ai Zheng 24 298 304 15757530 1:CAS:528:DC%2BD28XmtF2nsQ%3D%3D
36. T Yamada AM Fialho V Punj L Bratescu TK Gupta AM Chakrabarty 2005 Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity Cell Microbiol 7 1418 1431 16153242 10.1111/j.1462-5822. 2005.00567.x 1:CAS:528:DC%2BD2MXhtVGmurvM (Pubitemid 41335246)
37. JD Schwartz EK Rowinsky H Youssoufian B Pytowski Y Wu 2010 Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1) Cancer 116 1027 1032 20127948 10.1002/cncr.24789 1:CAS:528:DC%2BC3cXivVCnsLw%3D
38. T Matsumoto L Claesson-Welsh 2001 VEGF receptor signal transduction Sci STKE 2001 RE21 11741095 10.1126/stke.2001.112.re21 1:STN:280: DC%2BD3MnpsVekuw%3D%3D
39. L Claesson-Welsh 2003 Signal transduction by vascular endothelial growth factor receptors Biochem Soc Trans 31 20 24 12546646 10.1042/BST0310020 1:CAS:528:DC%2BD3sXptF2guw%3D%3D (Pubitemid 36241390)
40. C Gong KV Stoletov BI Terman 2004 VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization Angiogenesis 7 313 321 15886875 10.1007/s10456-004-7960-2 1:CAS:528: DC%2BD2MXktVajt7Y%3D (Pubitemid 40767933)
41. DJ Webb JT Parsons AF Horwitz 2002 Adhesion assembly, disassembly and turnover in migrating cells-over and over and over again Nat Cell Biol 4 E97 E100 11944043 10.1038/ncb0402-e97 1:CAS:528:DC%2BD38XivV2jt78%3D (Pubitemid 34308850)
42. SM Keezer SE Ivie HC Krutzsch A Tandle SK Libutti DD Roberts 2003 Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin Cancer Res 63 6405 6412 14559830 1:CAS:528:DC%2BD3sXotV2isrg%3D (Pubitemid 37255190)
43. LH Romer KG Birukov JG Garcia 2006 Focal adhesions: paradigm for a signaling nexus Circ Res 98 606 616 16543511 10.1161/01.RES.0000207408.31270.db 1:CAS:528:DC%2BD28XitFOiu74%3D
44. M Kowanetz N Ferrara 2006 Vascular endothelial growth factor signaling pathways: therapeutic perspective Clin Cancer Res 12 5018 5022 16951216 10.1158/1078-0432.CCR-06-1520 1:CAS:528:DC%2BD28XovF2huro%3D (Pubitemid 44453326)
45. DH Ausprunk J Folkman 1977 Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis Microvasc Res 14 53 65 895546 10.1016/0026-2862(77)90141-8 1:STN:280: DyaE2s3lsVegtQ%3D%3D (Pubitemid 8153798)
46. HM DeLisser M Christofidou-Solomidou RM Strieter, et al. 1997 Involvement of endothelial PECAM-1/CD31 in angiogenesis Am J Pathol 151 671 677 9284815 1:CAS:528:DyaK2sXmt1Sqtbs%3D (Pubitemid 27385598)
47. SO Lie B Schofield 1973 Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine Biochem Pharmacol 22 3109 3114 4271529 10.1016/0006-2952(73)90197-4 1:CAS:528:DyaE2cXhtVersrY%3D
48. PR Somanath OV Razorenova J Chen TV Byzova 2006 Akt1 in endothelial cell and angiogenesis Cell Cycle 5 512 518 16552185 10.4161/cc.5.5.2538 1:CAS:528:DC%2BD28Xkslejsr8%3D (Pubitemid 43340529)
49. ST Lim XL Chen Y Lim, et al. 2008 Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation Mol Cell 29 9 22 18206965 10.1016/j.molcel.2007.11.031 1:CAS:528:DC%2BD1cXhtlWjt7g%3D
50. Y Ogawara S Kishishita T Obata, et al. 2002 Akt enhances Mdm2-mediated ubiquitination and degradation of p53 J Biol Chem 277 21843 21850 11923280 10.1074/jbc.M109745200 1:CAS:528:DC%2BD38Xksl2jsLw%3D (Pubitemid 34952337)
51. WG Cance VM Golubovskaya 2008 Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal 1 pe22 18493017 10.1126/stke.120pe22
52. ES Kandel N Hay 1999 The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB Exp Cell Res 253 210 229 10579924 10.1006/excr.1999.4690 1:CAS:528:DyaK1MXnsF2it7s%3D
53. MJ Cross L Claesson-Welsh 2001 FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition Trends Pharmacol Sci 22 201 207 11282421 10.1016/S0165-6147(00)01676-X 1:CAS:528:DC%2BD3MXit1Wntr8%3D (Pubitemid 32244307)
54. RS Bhide LJ Lombardo JT Hunt, et al. 2010 The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases Mol Cancer Ther 9 369 378 20103604 10.1158/1535-7163.MCT-09-0472 1:CAS:528: DC%2BC3cXhslektbg%3D
55. SJ Jeong CA Pise-Masison MF Radonovich HU Park JN Brady 2005 Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells Oncogene 24 6719 6728 16007163 10.1038/sj.onc.1208825 1:CAS:528:DC%2BD2MXhtVOjsrzL (Pubitemid 41486802)
56. X Cheng W Xia JY Yang, et al. 2010 Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis Cancer Res 70 7684 7689 20841468 10.1158/0008-5472.CAN-09-3231 1:CAS:528:DC%2BC3cXht1akt7fI